Petco Health & Wellness Company, Inc.

Annual Trend FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 TTM
Total net sales $4.4b
$4.9b +10.95%
$5.8b +18.03%
$6.0b +3.94%
$6.3b +3.63%
$6.1b -2.22%
$6.0b -2.53%
Total cost of sales $2.5b
$2.8b +11.29%
$3.4b +20.16%
$3.6b +6.75%
$3.9b +8.11%
$3.8b -2.80%
$3.7b -3.58%
Gross profit $1.9b
$2.1b +10.50%
$2.4b +15.18%
$2.4b +0.02%
$2.4b -3.02%
$2.3b -1.25%
$2.3b -0.83%
$2.3b +0.19%
Selling, general and administrative expenses $1.8b $1.9b $2.2b $2.2b $2.3b $2.3b $2.2b $2.2b
Operating income (loss) $110.6m
$194.4m +75.79%
$266.1m +36.85%
$225.6m -15.23%
($1.2b) -623.28%
$7.1m +100.60%
$120.4m +1608.03%
$128.7m +6.86%
Interest expense $253.0m $219.1m $77.4m $101.6m $150.9m $143.5m $131.2m $130.5m
Interest income ($335k) ($653k) ($62k) ($1.0m) ($3.4m) ($3.7m) ($6.3m) $6.4m
Other non-operating income ($34.5m) $12.7m ($4.7m) ($4.8m) $0
Loss before income taxes and income from equity method investees ($142.1m) ($41.6m) $202.4m $112.3m ($1.3b) ($128.0m) ($5.0m)
Income from equity method investees ($2.4m) ($6.5m) ($10.9m) ($13.0m) ($16.2m) ($18.7m) ($20.4m)
Income tax expense (benefit) ($35.7m) ($3.3m) $53.5m $35.3m ($27.6m) ($7.5m) $6.3m $8.0m
Consolidated net income (loss) ($104.0m) ($31.7m) $159.8m $89.9m ($1.3b) ($101.8m) $9.1m
Net income (loss) attributable to Class A and B-1 common stockholders ($95.9m) ($26.5m) $164.4m $90.8m ($1.3b) ($101.8m) $9.1m $5.6m
Net loss attributable to noncontrolling interest ($8.1m) ($5.3m) ($4.6m) ($891k) $0 $0
Basic ($0.46) ($125.70) $0.62 $0.34 ($4.79) ($0.37) $0.03 $0.02
Diluted ($0.46) ($125.70) $0.62 $0.34 ($4.79) ($0.37) $0.03 $5,581,000.00
Goodwill impairment $0 $0 $1.2b $0 $0
Loss on partial extinguishment of debt $17.5m $20.8m $920k $565k

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.